SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000905718-21-000283
Filing Date
2021-02-16
Accepted
2021-02-16 16:28:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A forwardpharma_13gam1dec3120.htm SC 13G/A 36663
  Complete submission text file 0000905718-21-000283.txt   38126
Mailing Address 60 EAST 42ND STREET 9TH FLOOR NEW YORK NY 10165
Business Address 60 EAST 42ND STREET 9TH FLOOR NEW YORK NY 10165 212-446-2465
Newtyn Management, LLC (Filed by) CIK: 0001569241 (see all company filings)

IRS No.: 453017573 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address OSTERGADE 24A, 1 COPENHAGEN G7 1100
Business Address OSTERGADE 24A, 1 COPENHAGEN G7 1100 0114533444242
Forward Pharma A/S (Subject) CIK: 0001604924 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88394 | Film No.: 21639117
SIC: 2834 Pharmaceutical Preparations